University of Wollongong, School of Medicine, Faculty of Science, Medicine and Health, Wollongong, New South Wales, 2522, Australia.
Illawarra Health and Medical Research Institute, Wollongong, New South Wales, 2522, Australia.
BMC Nephrol. 2020 Jun 5;21(1):215. doi: 10.1186/s12882-020-01805-w.
There is mounting evidence that individuals with kidney disease and kidney stones have an abnormal gut microbiota composition. No studies to date have summarised the evidence to categorise how the gut microbiota profile of these individuals may differ from controls. Synthesis of this evidence is essential to inform future clinical trials. This systematic review aims to characterise differences of the gut microbial community in adults with kidney disease and kidney stones, as well as to describe the functional capacity of the gut microbiota and reporting of diet as a confounder in these studies.
Included studies were those that investigated the gut microbial community in adults with kidney disease or kidney stones and compared this to the profile of controls. Six scientific databases (CINHAL, Medline, PubMed, Scopus, Web of Science and Cochrane Library), as well as selected grey literature sources, were searched. Quality assessment was undertaken independently by three authors. The system of evidence level criteria was employed to quantitatively evaluate the alteration of microbiota by strictly considering the number, methodological quality and consistency of the findings. Additional findings relating to altered functions of the gut microbiota, dietary intakes and dietary methodologies used were qualitatively summarised.
Twenty-five articles met the eligibility criteria and included data from a total of 892 adults with kidney disease or kidney stones and 1400 controls. Compared to controls, adults with kidney disease had increased abundances of several microbes including Enterobacteriaceae, Streptococcaceae, Streptococcus and decreased abundances of Prevotellaceae, Prevotella, Prevotella 9 and Roseburia among other taxa. Adults with kidney stones also had an altered microbial composition with variations to Bacteroides, Lachnospiraceae NK4A136 group, Ruminiclostridium 5 group, Dorea, Enterobacter, Christensenellaceae and its genus Christensenellaceae R7 group. Differences in the functional potential of the microbial community between controls and adults with kidney disease or kidney stones were also identified. Only three of the 25 articles presented dietary data, and of these studies, only two used a valid dietary assessment method.
The gut microbiota profile of adults with kidney disease and kidney stones differs from controls. Future study designs should include adequate reporting of important confounders such as dietary intake to assist with interpretation of findings.
越来越多的证据表明,患有肾脏疾病和肾结石的个体肠道微生物群落组成异常。迄今为止,尚无研究总结这些个体的肠道微生物群特征可能与对照者有何不同。综合这些证据对于指导未来的临床试验至关重要。本系统综述旨在描述患有肾脏疾病和肾结石的成年人肠道微生物群落的差异,并描述肠道微生物群的功能能力以及这些研究中饮食作为混杂因素的报告。
纳入的研究是那些调查患有肾脏疾病或肾结石的成年人肠道微生物群落,并将其与对照组进行比较的研究。共检索了 6 个科学数据库(CINHAL、Medline、PubMed、Scopus、Web of Science 和 Cochrane Library)以及一些选定的灰色文献来源。三位作者独立进行了质量评估。采用证据水平标准系统,严格考虑研究结果的数量、方法学质量和一致性,定量评估微生物群落的变化。定性总结了与肠道微生物群改变功能、饮食摄入和饮食方法相关的其他发现。
25 篇文章符合纳入标准,共纳入 892 名患有肾脏疾病或肾结石的成年人和 1400 名对照者的数据。与对照组相比,患有肾脏疾病的成年人肠道中某些微生物的丰度增加,包括肠杆菌科、链球菌科、链球菌属,而普雷沃氏菌科、普雷沃氏菌属、普雷沃氏菌 9 和罗氏菌属等其他分类群的丰度降低。肾结石患者的肠道微生物组成也发生了改变,包括拟杆菌科、lachnospiraceae NK4A136 群、瘤胃菌科 5 群、Dorea、肠杆菌科和 Christensenellaceae 及其属 Christensenellaceae R7 群。还确定了对照组和患有肾脏疾病或肾结石的成年人肠道微生物群落的功能潜力存在差异。25 篇文章中有 3 篇报道了饮食数据,其中只有 2 篇研究使用了有效的饮食评估方法。
患有肾脏疾病和肾结石的成年人的肠道微生物群特征与对照组不同。未来的研究设计应包括对重要混杂因素(如饮食摄入)的充分报告,以协助解释研究结果。